EF1a-dCas9-VP64 Citations (1)

Originally described in: Leveraging CRISPR activation for rapid assessment of gene editing products in human pluripotent stem cells.
Wu Y, Zhong A, Evangelisti A, Sidharta M, Danwei H, Studer L, Zhou T Stem Cell Reports. 2025 Apr 25:102499. doi: 10.1016/j.stemcr.2025.102499. PubMed Journal

---

Articles Citing EF1a-dCas9-VP64

Articles
Protocol to rapidly verify silent gene reporter in human pluripotent stem cells using CRISPR activation. Wu Y, Zhong A, Ramirez B, Wai SS, Zhou T. STAR Protoc. 2025 Oct 25;6(4):104164. doi: 10.1016/j.xpro.2025.104164. PubMed

If you have published an article using this material, please email us at to have your article added to this page.